What is Alibaba Health Information Technology Days Payable?
Alibaba Health Information TechnologyALBBY 73 Days Payable is 43.79 as of Mar. 2026, which is 32% below its 10-year median of 63.93. GuruFocus rates ALBBY with a GF Scoreâ„¢ of 73/100 and a GF Valueâ„¢ of $14.25 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 607 Healthcare Providers & Services companies, Alibaba Health Information Technology ranks worse than 62.11% on this metric.
ALBBY's Days Payable is ranked worse than 62.11% of 607
companies
in the Healthcare Providers & Services industry
Industry Median: 58.16
vs ALBBY: 43.62
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology Days Payable Chart
Alibaba Health Information Technology Days Payable Competitor Comparison
For the Pharmaceutical Retailers subindustry, Alibaba Health Information Technology's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alibaba Health Information Technology Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Alibaba Health Information Technology's Days Payable distribution charts can be found below:
* The bar in red indicates where Alibaba Health Information Technology's Days Payable falls into.
Alibaba Health Information Technology Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alibaba Health Information Technology (ALBBY) has a Days Payable of 43.79 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alibaba Health Information Technology and its competitors. This is 32% below median its historical median of 63.93. Over the past decade, Alibaba Health Information Technology's Days Payable has ranged from 40.10 to 82.32. According to the industry distribution chart, Alibaba Health Information Technology ranks #377 out of 607 companies in the Healthcare Providers & Services industry, placing it in the top 62.1%.
Is Alibaba Health Information Technology's Days Payable too high?
Alibaba Health Information Technology's current Days Payable of 43.79 is 32% below median its 10-year median of 63.93. Over the past 10 years, this metric has ranged from a low of 40.10 to a high of 82.32. The Healthcare Providers & Services industry median Days Payable is 58.16. Alibaba Health Information Technology's value of 43.79 is 24.7% below this industry median. Based on the distribution chart, Alibaba Health Information Technology ranks #377 out of 607 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Alibaba Health Information Technology has a GF Scoreâ„¢ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alibaba Health Information Technology's Days Payable compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Alibaba Health Information Technology ranks #377 out of 607 companies for Days Payable. This places Alibaba Health Information Technology in the lower half of its industry. The industry median Days Payable is 58.16. Alibaba Health Information Technology's value of 43.79 is 24.7% below this benchmark. Historically, Alibaba Health Information Technology's own Days Payable has ranged from 40.10 to 82.32 over the past decade. While the company's 10-year median is 63.93 vs. the industry median of 58.16, Alibaba Health Information Technology has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.16, based on 607 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alibaba Health Information Technology's current Days Payable of 43.79 is 24.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Alibaba Health Information Technology and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alibaba Health Information Technology's current Days Payable is 43.79, which is 32% below median its own 10-year median of 63.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alibaba Health Information Technology stock overvalued right now?
Based on GuruFocus' analysis, Alibaba Health Information Technology (ALBBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.25, compared to a current price of $8.46 — trading 40.6% below its estimated fair value. The current Days Payable is 43.79, which is 32% below median its 10-year median of 63.93 and 24.7% below the Healthcare Providers & Services industry median of 58.16. Alibaba Health Information Technology's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Alibaba Health Information Technology (ALBBY), the current Days Payable is 43.79 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alibaba Health Information Technology (ALBBY) Overvalued in 2026?
Based on GuruFocus' analysis, Alibaba Health Information Technology stock appears to be undervalued.
The current stock price of $8.46 is trading 40.6% below its estimated GF Value™ of $14.25.
GuruFocus considers Alibaba Health Information Technology to be Significantly Undervalued.
Key valuation signals for ALBBY:
Days Payable: 43.79 (32% below median its 10-year median of 63.93)
GF Value™: $14.25 vs. price of $8.46 (40.6% below fair value)
Industry Position: 24.7% below the Healthcare Providers & Services median (#377 of 607)
No single metric tells the full story. See the ALBBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alibaba Health Information Technology Business Description
Alibaba Health is of one of China's leading e-commerce platform specializing in healthcare-related products, including prescription drugs, OTC drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba's Tmall app and Alipay. The company also provides online consultation services in a separate app although its e-commerce businesses remain its core competency in the long-term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of GMV. AliHealth is 63.74% owned by its parent company, Alibaba Group.
73GF Score
Get the complete analysis for ALBBY
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALBBY has been successfully added to your 
